2-(4-Bromophenyl)-N-hydroxyacetimidamide (cas: 422560-40-5) belongs to organobromine compounds. Most organobromine compounds, like most organohalide compounds, are relatively nonpolar. Bromine-containing agents predominate because not only are they more efficient than similar chlorine-containing species, but also the high atomic weight of bromine ensures that it is present in a high mass fraction within most organobromine compounds.Synthetic Route of C8H9BrN2O
Synthesis, SAR, and Series Evolution of Novel Oxadiazole-Containing 5-Lipoxygenase Activating Protein Inhibitors: Discovery of 2-[4-(3-{(R)-1-[4-(2-Amino-pyrimidin-5-yl)-phenyl]-1-cyclopropyl-ethyl}-[1,2,4]oxadiazol-5-yl)-pyrazol-1-yl]-N,N-dimethyl-acetamide (BI 665915) was written by Takahashi, Hidenori;Riether, Doris;Bartolozzi, Alessandra;Bosanac, Todd;Berger, Valentina;Binetti, Ralph;Broadwater, John;Chen, Zhidong;Crux, Rebecca;De Lombaert, Stephane;Dave, Rajvee;Dines, Jonathon A.;Fadra-Khan, Tazmeen;Flegg, Adam;Garrigou, Michael;Hao, Ming-Hong;Huber, John;Hutzler, J. Matthew;Kerr, Steven;Kotey, Adrian;Liu, Weimin;Lo, Ho Yin;Loke, Pui Leng;Mahaney, Paige E.;Morwick, Tina M.;Napier, Spencer;Olague, Alan;Pack, Edward;Padyana, Anil K.;Thomson, David S.;Tye, Heather;Wu, Lifen;Zindell, Renee M.;Abeywardane, Asitha;Simpson, Thomas. And the article was included in Journal of Medicinal Chemistry in 2015.Synthetic Route of C8H9BrN2O The following contents are mentioned in the article:
The synthesis, structure-activity relationship (SAR), and evolution of a novel series of oxadiazole-containing 5-lipoxygenase-activating protein (FLAP) inhibitors are described. The use of structure-guided drug design techniques provided compounds that demonstrated excellent FLAP binding potency (IC50 < 10 nM) and potent inhibition of LTB4 synthesis in human whole blood (IC50 < 100 nM). Optimization of binding and functional potencies, as well as physicochem. properties resulted in the identification of compound 69 (I, BI 665915) that demonstrated an excellent cross-species drug metabolism and pharmacokinetics (DMPK) profile and was predicted to have low human clearance. In addition, 69 was predicted to have a low risk for potential drug-drug interactions due to its cytochrome P 450 3A4 profile. In a murine ex vivo whole blood study, 69 demonstrated a linear dose-exposure relationship and a dose-dependent inhibition of LTB4 production This study involved multiple reactions and reactants, such as 2-(4-Bromophenyl)-N-hydroxyacetimidamide (cas: 422560-40-5Synthetic Route of C8H9BrN2O).
2-(4-Bromophenyl)-N-hydroxyacetimidamide (cas: 422560-40-5) belongs to organobromine compounds. Most organobromine compounds, like most organohalide compounds, are relatively nonpolar. Bromine-containing agents predominate because not only are they more efficient than similar chlorine-containing species, but also the high atomic weight of bromine ensures that it is present in a high mass fraction within most organobromine compounds.Synthetic Route of C8H9BrN2O
Referemce:
Bromide – Wikipedia,
bromide – Wiktionary